We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Mr
David
Fleet
+44 (0)7533002238
davidfleet@manentia.co.uk
Mr
David
Fleet
+44 (0)7533002238
davidfleet@manentia.co.uk
Prof
Andrew
Messenger
+44 (0)7952 926139
a.g.messenger@sheffield.ac.uk
More information about this study, what is involved and how to take part can be found on the study website.
Alopecia areata
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
STS-01 is being developed to address the need for an effective, safe and convenient non-steroidal topical treatment for alopecia areata (patchy hair loss). The product builds on a mechanism with a well-established safety profile in dermatology, and existing evidence of its effectiveness in this condition through targeting key relevant cytokines. STS-01 has been modified to maximise the effectiveness of this mechanism and offer a cosmetically elegant topical cream. The study aims to assess the effectiveness, safety and dose-response characteristics of STS-01 for the treatment of alopecia areata
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
You can take part if:
You may not be able to take part if:
Severe alopecia areata (totalis/universalis)
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Mr
David
Fleet
+44 (0)7533002238
davidfleet@manentia.co.uk
Prof
Andrew
Messenger
+44 (0)7952 926139
a.g.messenger@sheffield.ac.uk
Mr
David
Fleet
+44 (0)7533002238
davidfleet@manentia.co.uk
More information about this study, what is involved and how to take part can be found on the study website.
The study is sponsored by Soterios Ltd and funded by Soterios Ltd.
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Or CPMS 50463
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
